Description

Mounjaro Injection (2.5mg, 5mg, 7.5mg, 10mg)

Mounjaro Injection contains tirzepatide, a prescription medicine used alongside diet and physical activity to help manage type 2 diabetes and, in eligible adults, support weight management. It works on two hormone pathways involved in blood glucose regulation and appetite.

What Is Mounjaro Injection?

Mounjaro is supplied as a once-weekly injection and is available in several strengths, including 2.5mg, 5mg, 7.5mg and 10mg. The appropriate strength depends on the individual’s treatment plan and response.

For weight management, tirzepatide may be prescribed for adults who meet specific eligibility criteria based on body mass index (BMI) and weight-related health conditions. It should be used alongside a reduced-calorie diet and increased physical activity.

How Does Mounjaro Work?

Tirzepatide acts on both GIP and GLP-1 receptors. These hormones help regulate blood glucose and appetite. Mounjaro can increase insulin release when blood glucose is elevated, reduce glucagon secretion and slow the movement of food through the stomach.

It can also reduce appetite and food intake, which contributes to weight loss in people using it as part of a structured weight-management programme.

Mounjaro Strengths

• Active ingredient: Tirzepatide
• Available strengths: 2.5mg, 5mg, 7.5mg and 10mg
• Dosage form: Solution for injection
• Administration: Subcutaneous injection
• Frequency: Once weekly
• Uses: Type 2 diabetes and, where appropriate, weight management
• Medicine class: GIP/GLP-1 receptor agonist
• Prescription status: Prescription medicine in the UK

Mounjaro Injection Safety Information

Common side effects include nausea, diarrhoea, vomiting, constipation and abdominal discomfort. These effects may be more noticeable when treatment is started or the dose is increased.

Mounjaro can contribute to dehydration if vomiting or diarrhoea is severe. Seek medical advice if you cannot keep fluids down or develop symptoms of significant dehydration.

There is also a risk of low blood sugar (hypoglycaemia) when tirzepatide is used with certain diabetes medicines, particularly insulin or sulfonylureas. Your healthcare professional may need to adjust other diabetes medicines.

Seek urgent medical attention for severe, persistent abdominal pain, especially if it radiates to the back, as this can be a sign of pancreatitis.

Mounjaro in the UK

Mounjaro is a prescription medicine in the UK. The correct strength and treatment schedule should be determined by an appropriately qualified healthcare professional. Do not change the dose or frequency of injections without medical advice.